Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CVS | Common Stock | Options Exercise | $7.88M | +101K | +16.6% | $78.05 | 709K | Dec 15, 2022 | Direct | |
transaction | CVS | Common Stock | Sale | -$9.94M | -101K | -14.24% | $98.40 | 608K | Dec 15, 2022 | Direct | F1 |
transaction | CVS | Common Stock | Options Exercise | $2.27M | +36.5K | +6% | $62.21 | 645K | Dec 15, 2022 | Direct | |
transaction | CVS | Common Stock | Sale | -$3.58M | -36.5K | -5.66% | $98.24 | 608K | Dec 15, 2022 | Direct | F2 |
holding | CVS | Common Stock | 159K | Dec 15, 2022 | By GRAT | ||||||
holding | CVS | Stock Unit | 47.3K | Dec 15, 2022 | Direct |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CVS | Stock Option | Options Exercise | $0 | -101K | -80.64% | $0.00 | 24.2K | Dec 15, 2022 | Common Stock | 101K | $78.05 | Direct | F3 |
transaction | CVS | Stock Option | Options Exercise | $0 | -36.5K | -100% | $0.00* | 0 | Dec 15, 2022 | Common Stock | 36.5K | $62.21 | Direct | F4 |
holding | CVS | Stock Option | 71.7K | Dec 15, 2022 | Common Stock | 71.7K | $104.82 | Direct | F5 | |||||
holding | CVS | Stock Option | 50.5K | Dec 15, 2022 | Common Stock | 50.5K | $54.19 | Direct | F6 | |||||
holding | CVS | Stock Option | 98.6K | Dec 15, 2022 | Common Stock | 98.6K | $58.34 | Direct | F7, F8 | |||||
holding | CVS | Stock Option | 117K | Dec 15, 2022 | Common Stock | 117K | $74.30 | Direct | F9 | |||||
holding | CVS | Stock Option | 46.8K | Dec 15, 2022 | Common Stock | 46.8K | $101.09 | Direct | F10 |
Id | Content |
---|---|
F1 | All sales were effected pursuant to a Rule 10b5-1 plan. |
F2 | All sales were effected pursuant to a Rule 10b5-1 plan. |
F3 | Option became exercisable in four equal annual installments, commencing 4/3/2018. |
F4 | Option became exercisable in four equal annual installments, commencing 4/1/2019. |
F5 | Option became exercisable in four equal annual installments, commencing 4/1/2017. |
F6 | Option became exercisable in four equal annual installments, commencing 4/1/2020. |
F7 | The number of shares subject to the option were calculated using a 30-day average price. |
F8 | Option became exercisable in four equal annual installments, commencing 4/1/2021. |
F9 | Option became exercisable in four equal annual installments, commencing 4/1/2022. |
F10 | Option becomes exercisable in four equal annual installments, commencing 4/1/2023. |